fbpx

World Pharma News

12

Nov2019
Basel, 11 November 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive data from the pivotal ... Read More

12

Nov2019
The P-III program involves assessing of Roxadustat vs PBO and epoetin alfa in 9,000+ NDD and DD & ... Read More

12

Nov2019
Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. ... Read More

12

Nov2019
The FDA has accepted the supplemental biologics license application and granted breakthrough therapy designation to nivolumab (Opdivo) plus ... Read More
Share this: